Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries

INTRODUCTION: The objective of this study was to evaluate real-world treatment patterns of type 2 diabetes (T2D) patients initiating glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Germany (GE), the United Kingdom (UK), France (FR), the Netherlands (NE), Belgium (BE), and Sweden (SE). METHO...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Ther
Hlavní autoři: Divino, Victoria, DeKoven, Mitch, Hallinan, Shawn, Varol, Nebibe, Wirta, Sara Bruce, Lee, Won Chan, Reaney, Matthew
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2014
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4269654/
https://ncbi.nlm.nih.gov/pubmed/25366334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-014-0087-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky